Protein-only nanocapsules induce cross-presentation in dendritic cells, demonstrating potential as an antigen delivery system
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 28, 102234
Abstract
No abstract availableKeywords
Funding Information
- Cass Foundation
This publication has 60 references indexed in Scilit:
- Immunization with Biodegradable Nanoparticles Efficiently Induces Cellular Immunity and Protects against Influenza Virus InfectionThe Journal of Immunology, 2013
- Protective Antibody and CD8+ T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle VaccinePLOS ONE, 2012
- The pathway of cross‐presentation is influenced by the particle size of phagocytosed antigenImmunology, 2012
- The nanosilica hazard: another variable entityParticle and Fibre Toxicology, 2010
- Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activationVaccine, 2010
- Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticlesJournal of Controlled Release, 2010
- Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial CellsACS Nano, 2009
- C-type lectins and phagocytosisImmunobiology, 2009
- A low-viscosity epoxy resin embedding medium for electron microscopyJournal of Ultrastructure Research, 1969
- Adsorption of Gases in Multimolecular LayersJournal of the American Chemical Society, 1938